PanTheryx Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 51

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 12

  • Investments
  • 4

PanTheryx General Information

Description

Provider of intestinal research and medical nutrition products intended to address serious gastrointestinal microbiome-related health conditions. The company is focused on pharmaceutical research, development and commercialization of products that target the gastrointestinal microbiome, enabling pharmaceutical and consumer healthcare companies to deliver safe and efficient anti-diarrhea medicine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Corporate Office
  • 4845 Pearl East Circle
  • Suite 101
  • Boulder, CO 80301
  • United States
+1 (602) 000-0000

PanTheryx Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PanTheryx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PanTheryx‘s full profile, request access.

Request a free trial

PanTheryx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of intestinal research and medical nutrition products intended to address serious gastrointestinal microbiome-r
Pharmaceuticals
Boulder, CO
51 As of 2022
00000
0000000 0000 00000

00000

oluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occae
000000000000000
Basel, Switzerland
000000 As of 0000
000.00
000000000000 000.00

000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident
0000000000000
Stockholm, Sweden
0 As of 0000
00.000
00.00 0000-00-00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PanTheryx Competitors (45)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Roche Corporation Basel, Switzerland 000000 000.00 000000000000 000.00
MetaboGen Corporate Backed or Acquired Stockholm, Sweden 0 00.000 00000000000
AbbVie Corporation North Chicago, IL 00000 000.00 000000000 000.00
Ironwood Pharmaceuticals Formerly VC-backed Boston, MA 000 00000 000000000 00000
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA 000 00000 000000&0
You’re viewing 5 of 45 competitors. Get the full list »

PanTheryx Patents

PanTheryx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220362303-A1 Stabilized colostrum compositions Pending 26-Feb-2021 0000000000
AU-2022227009-A1 Stabilized colostrum compositions Pending 26-Feb-2021 0000000000
EP-4297589-A1 Stabilized colostrum compositions Pending 26-Feb-2021 0000000000
US-20200323954-A1 Methods and compositions for reducing gut ischemia/reperfusion-induced injury Inactive 10-Apr-2019 00000000000
US-20220047646-A1 Compositions for management of disorders of the gastrointestinal tract Pending 26-Feb-2019 A61K35/57
To view PanTheryx’s complete patent history, request access »

PanTheryx Executive Team (13)

Name Title Board Seat Contact Info
Wes Parris Chief Executive Officer, President and Board Member
George Stagnitti Executive Vice President & President of APS BioGroup/La Belle
Thomas Feeley Chief Operating Officer & Chief Financial Officer
Amy Gibbs Controller
Bimla Starzl Co-Founder
You’re viewing 5 of 13 executive team members. Get the full list »

PanTheryx Board Members (11)

Name Representing Role Since
00000 00000 00 Pegasus Capital Advisors Vice Chairman 000 0000
00000 00000000 00 PanTheryx Executive Chairman 000 0000
00000 00000 Pegasus Capital Advisors Board Member 000 0000
000000 00000000 PanTheryx Board Member 000 0000
000000 00 00 Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

PanTheryx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PanTheryx Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PanTheryx‘s full profile, request access.

Request a free trial

PanTheryx Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Trubiotics 28-Feb-2021 0000000000 Other Consumer Non-Durables 000 00000
Greenteaspoon 14-Oct-2020 0000000000 Biotechnology 000 00000
APS BioGroup 14-Feb-2017 0000000000 Other Pharmaceuticals and Biotechnology 0000 0000
La Belle Associates 01-Mar-2016 Buyout/LBO Food Products 0000 0000
To view PanTheryx’s complete investments history, request access »

PanTheryx Subsidiaries (2)

Company Name Industry Location Founded
La Belle Associates Food Products Bellingham, WA 1984
Trubiotics Other Consumer Non-Durables FL
To view PanTheryx’s complete subsidiaries history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »